{"id":11128,"date":"2018-04-03T13:41:23","date_gmt":"2018-04-03T11:41:23","guid":{"rendered":"https:\/\/www.mannheimerswartling.se\/?p=11128"},"modified":"2021-03-12T10:34:02","modified_gmt":"2021-03-12T09:34:02","slug":"bioinvent-international-ab-har-genomfort-en-riktad-nyemission-om-cirka-85-miljoner-kronor","status":"publish","type":"post","link":"https:\/\/www.mannheimerswartling.se\/uppdrag\/bioinvent-international-ab-har-genomfort-en-riktad-nyemission-om-cirka-85-miljoner-kronor\/","title":{"rendered":"BioInvent International AB har genomf\u00f6rt en riktad nyemission om cirka 85 miljoner kronor"},"content":{"rendered":"<p>BioInvent International har genomf\u00f6rt en riktad nyemission om cirka 85 miljoner kronor genom ett s.k. accelererat book building-f\u00f6rfarande.<\/p>\n<p>BioInvent International \u00e4r inriktat p\u00e5 forskning och utveckling av nya och first-in-class immunreglerande antikroppar f\u00f6r cancerbehandling. Bolaget har en sp\u00e4nnande preklinisk portf\u00f6lj baserad p\u00e5 nya immunmodulerande antikroppar riktade mot regulatoriska T-celler (T-reg) och tum\u00f6rassocierade myeloidceller. BioInvent Internationals aktier \u00e4r noterade p\u00e5 Nasdaq Stockholm.<\/p>\n<p>BioInvent International bitr\u00e4ddes av Mannheimer Swartling i samband med emissionen.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>BioInvent International har genomf\u00f6rt en riktad nyemission om cirka 85 miljoner kronor genom ett s.k. accelererat book building-f\u00f6rfarande. BioInvent International \u00e4r inriktat p\u00e5 forskning och\u2026<\/p>\n","protected":false},"author":7,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[3469],"tags":[],"class_list":["post-11128","post","type-post","status-publish","format-standard","hentry","category-uppdrag","business-group-publik-ma-och-aktiemarknad"],"acf":[],"lang":"sv","translations":{"sv":11128,"en":11130},"pll_sync_post":[],"_links":{"self":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts\/11128"}],"collection":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/comments?post=11128"}],"version-history":[{"count":2,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts\/11128\/revisions"}],"predecessor-version":[{"id":14864,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts\/11128\/revisions\/14864"}],"wp:attachment":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/media?parent=11128"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/categories?post=11128"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/tags?post=11128"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}